The DOI matches its Crossref record.
Phosphorylation-dependent Conformational Switch in Spin-labeled Phospholamban Bound to SERCA
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These resonances are attributed to the dynamic domain Ib residues, and their disappearance is consistent with SERCA binding, which requires the unwinding of the juxtamembrane region, and a concomitant reduction of the tilt angle to re-establish hydrophobic matching with the thickness of the lipid bilayer (Karim et al., 2006; Gustavsson et al., 2013).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Karim et al., 2006
In the citing paper
“The latter model speculates that the reversal of the inhibitory function of PLN is due to a complete dissociation of this regulin from the ATPase; but this is not supported by spectroscopic evidence either in vitro or in cell (Karim et al., 2006; Gustavsson et al., 2013; Dong and Thomas, 2014; Bidwell et al., 2011; Martin et al., 2018).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Karim et al., 2006
In the citing paper
“These spectral changes suggest a reorganization of PLN-SERCA packing interactions, rather than a complete dissociation of the complex, consistent with prior MAS-ssNMR, EPR, and FRET measurements (Karim et al., 2006; Gustavsson et al., 2013; Dong and Thomas, 2014; Bidwell et al., 2011).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Karim et al., 2006
In the citing paper
“Also, our laboratory [65–69] and others [70–74] discovered that PLN’s cytoplasmic region exists in equilibrium between two inhibitory conformations: an ordered T (tense) state (helical and membrane bound) and a disordered R (relaxed) state (dynamic and membrane detached, Figure 6A), the latter of which is characterized by a flexible cytoplasmic domain available for a putative, non-inhibitory SERCA”
From Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region (2020) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 39
- Lindemann, 1983, Beta-adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles, J. Biol. Chem., 258, 464, 10.1016/S0021-9258(18)33279-4 · DOI · Paper page
- MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nature Rev. Mol. Cell Biol., 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest., 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
- Sande, 2002, Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity, Cardiovasc. Res., 53, 382, 10.1016/S0008-6363(01)00489-8 · DOI
- Schmidt, 2001, Phospholamban: a promising therapeutic target in heart failure?, Cardiovasc. Drugs Ther., 15, 387, 10.1023/A:1013381204658 · DOI
- Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- Thomas, 1998, Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban, Ann. N Y Acad. Sci., 853, 186, 10.1111/j.1749-6632.1998.tb08266.x · DOI
- MacLennan, 1998, Sites of regulatory interaction between calcium ATPases and phospholamban, Ann. N Y Acad. Sci., 853, 31, 10.1111/j.1749-6632.1998.tb08254.x · doi:10.1111/j.1749-6632.1998.tb08254.x
- Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Mueller, 2004, Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer, Biochemistry, 43, 8754, 10.1021/bi049732k · DOI
- Mueller, 2004, SERCA structural dynamics induced by ATP and calcium, Biochemistry, 43, 12846, 10.1021/bi0489457 · doi:10.1021/bi0489457
- Negash, 2000, Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase, Biochem. J., 351, 195, 10.1042/0264-6021:3510195 · doi:10.1042/0264-6021:3510195
- Chen, 2002, Phosphorylation induces a conformational transition near the lipid–water interface of phospholamban reconstituted with the Ca-ATPase, Biochemistry, 41, 13965, 10.1021/bi0266030 · DOI
- Li, 2004, Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition, Biochemistry, 43, 3870, 10.1021/bi036183u · doi:10.1021/bi036183u
- Li, 2004, Phospholamban binds in a compact and ordered conformation to the Ca-ATPase, Biochemistry, 43, 455, 10.1021/bi035424v · DOI
- Reddy, 1999, Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry, 38, 3954, 10.1021/bi981795d · doi:10.1021/bi981795d
- Li, 1999, A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban, Biophys. J., 76, 2587, 10.1016/S0006-3495(99)77411-4 · DOI
- Autry, 1997, Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation, J. Biol. Chem., 272, 15872, 10.1074/jbc.272.25.15872 · DOI · Paper page
- Lockwood, 2003, Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban, Biopolymers, 69, 283, 10.1002/bip.10365 · doi:10.1002/bip.10365
- Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys. J., 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI
- Mascioni, 2002, Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban, J. Am. Chem. Soc., 124, 9392, 10.1021/ja026507m · doi:10.1021/ja026507m
- Kirby, 2004, Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase, Biochemistry, 43, 5842, 10.1021/bi035749b · doi:10.1021/bi035749b
- Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl Acad. Sci. USA, 101, 14437, 10.1073/pnas.0402801101 · doi:10.1073/pnas.0402801101
- Metcalfe, 2005, Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban, Biochemistry, 44, 4386, 10.1021/bi047571e · DOI
- Zamoon, 2005, Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation, Proc. Natl Acad. Sci. USA, 102, 4747, 10.1073/pnas.0406039102 · DOI
- Reddy, 1999, Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure, J. Biol. Chem., 274, 7649, 10.1074/jbc.274.12.7649 · doi:10.1074/jbc.274.12.7649
- Jones, 2002, Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking, J. Biol. Chem., 277, 28319, 10.1074/jbc.M204085200 · DOI
- Metcalfe, 2004, (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles, Biophys. J., 87, 1205, 10.1529/biophysj.103.038844 · DOI
- Traaseth, 2006, Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex, J. Mol. Biol, 10.1016/j.jmb.2006.02.047 · DOI
- Karim, 2001, Role of cysteine residues in structural stability and function of a transmembrane helix bundle, J. Biol. Chem., 276, 38814, 10.1074/jbc.M104006200 · doi:10.1074/jbc.m104006200
- Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
- Berndt, 1995, Synthetic lipidation of peptides and amino acids: monolayer structure and properties, J. Am. Chem. Soc., 117, 9515, 10.1021/ja00142a019 · DOI · Paper page
- Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- Mayer, 2000, Characterization and quantitation of phospholamban and its phosphorylation state using antibodies, Biochem. Biophys. Res Commun., 267, 40, 10.1006/bbrc.1999.1920 · doi:10.1006/bbrc.1999.1920
- Fabiato, 1979, Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells, J. Physiol. (Paris), 75, 463
- Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI · Paper page
- Budil, 1996, Non-linear-least-squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg–Marquardt algorithm, J. Magn. Reson. A, 120, 155, 10.1006/jmra.1996.0113 · DOI · Paper page
Cited by
Weber, D. K., Reddy, U. V., Wang, S., Larsen, E. K., Gopinath, T., Gustavsson, M. B., Cornea, R. L., Thomas, D. D., De Simone, A., & Veglia, G. (2021) · eLife · doi:10.7554/elife.66226 · Cited by 51
Self-citationLarsen, E. K., Weber, D. K., Wang, S., Gopinath, T., Blackwell, D. J., Dalton, M. P., Robia, S. L., Gao, J., & Veglia, G. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183034 · Cited by 15
Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Metadata
- Authors
- Karim, C. B., Zhang, Z., Howard, E. C., Torgersen, K. D., & Thomas, D. D.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 358
- Issue
- 4
- Pages
- 1032-1040
- ISSN
- 0022-2836
- Cited by
- 106
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.